Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 4/2012

01.04.2012 | Rhinology

Psychophysiological and electrophysiological testing of olfactory and gustatory function in patients with multiple sclerosis

verfasst von: Sarah Bettina Dahlslett, Oender Goektas, Felix Schmidt, Lutz Harms, Heidi Olze, Franca Fleiner

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

The olfactory (OF) and gustatory function in multiple sclerosis (MS) patients and possible influencing variables of the disease, such as depression or fatigue, were determined. In an open prospective controlled clinical study 30 patients with MS and 30 healthy controls matched for age, sex and smoking-habits were investigated. With Mini Mental State Examination cognitive dysfunction was excluded, with Expanded Disability Status Scale the patient’s ability to accomplish the tests was ensured. The severity of depression was measured with the self-reported Beck Depression Inventory. The orthonasal olfactory function was derived with olfactory event related potentials (OERP) and TDI-score (Threshold, Discrimination and Identification, Sniffin’ Sticks). Retronasal olfactory function was tested with Taste-Powder-score, gustatory function with Taste-strip-score. There was a significant loss of olfactory function measured with TDI-score [12/30 (40%), p = 0.002] and gustatory function [5/23 (21.7%), p < 0.001] in MS-patients, 23.8% (5/21) of MS-patients showed hyposmia with OERPs, significantly correlating with the TDI-score (p = 0.03). The Expanded Disability Status scale score inversely correlated with the TDI-score (p = 0.002). This study confirms the incidence of olfactory disorder in MS-patients and reveals a frequent gustatory deficit. The Identification subtest can be proposed as a marker of the OF in MS-patients: it includes complex cognitive tasks and may be influenced by depression and fatigue, which are common symptoms of MS. It inversely correlates with the disability status.
Literatur
1.
Zurück zum Zitat Hawkes CH, Shepard BC, Kobal G (1997) Assessment of olfaction in multiple sclerosis. Evidence of dysfunction by olfactory evoked response and identification test. J Neurol Neurosurg Psychiatry 63:145–151PubMedCrossRef Hawkes CH, Shepard BC, Kobal G (1997) Assessment of olfaction in multiple sclerosis. Evidence of dysfunction by olfactory evoked response and identification test. J Neurol Neurosurg Psychiatry 63:145–151PubMedCrossRef
2.
Zurück zum Zitat Doty RL, LI C, Mannon LJ, Yousem DM (1998) Olfactory dysfunction in multiple sclerosis Relation to plaque load in inferior frontal and temporal lobes. Ann N Y Acad Sci 855:781–786PubMedCrossRef Doty RL, LI C, Mannon LJ, Yousem DM (1998) Olfactory dysfunction in multiple sclerosis Relation to plaque load in inferior frontal and temporal lobes. Ann N Y Acad Sci 855:781–786PubMedCrossRef
3.
Zurück zum Zitat Zivadinov R, Zorzon M, Monti Bragadin LV, Pagliaro G, Gazzato G (1999) Olfactory loss in multiple sclerosis. J Neurol Sci 168(2):127–130PubMedCrossRef Zivadinov R, Zorzon M, Monti Bragadin LV, Pagliaro G, Gazzato G (1999) Olfactory loss in multiple sclerosis. J Neurol Sci 168(2):127–130PubMedCrossRef
4.
Zurück zum Zitat Nocentini U, Giorgdano A, Castriota-Scanderberg A, Caltagirone C (2004) Parageusia: an unusual presentation of multiple sclerosis. Eur Neurol 51:123–124PubMedCrossRef Nocentini U, Giorgdano A, Castriota-Scanderberg A, Caltagirone C (2004) Parageusia: an unusual presentation of multiple sclerosis. Eur Neurol 51:123–124PubMedCrossRef
5.
Zurück zum Zitat Gottfried JA (2006) Smell: Central nervous processing. Adv Otorhinolaryngol 63:44–69PubMed Gottfried JA (2006) Smell: Central nervous processing. Adv Otorhinolaryngol 63:44–69PubMed
6.
Zurück zum Zitat Foley JF, Brandes DW (2009) Redefining functionality and treatment efficacy in multiple sclerosis. Neurology 72:S1–S11PubMedCrossRef Foley JF, Brandes DW (2009) Redefining functionality and treatment efficacy in multiple sclerosis. Neurology 72:S1–S11PubMedCrossRef
7.
Zurück zum Zitat Pollatos O, Albrecht J, Kopietz R, Linn J, Schoepf V, Kleemann AM et al (2007) Reduced olfactory function in subjects with depressive symptoms. J Affect Disord 102(1–3):101–108PubMedCrossRef Pollatos O, Albrecht J, Kopietz R, Linn J, Schoepf V, Kleemann AM et al (2007) Reduced olfactory function in subjects with depressive symptoms. J Affect Disord 102(1–3):101–108PubMedCrossRef
8.
Zurück zum Zitat Pause BM, Miranda A, Göder R, Aldenhoff JB, Ferstl R (2001) Reduced olfactory performance in patients with major depression. J Psychiatr Res 35:271–277PubMedCrossRef Pause BM, Miranda A, Göder R, Aldenhoff JB, Ferstl R (2001) Reduced olfactory performance in patients with major depression. J Psychiatr Res 35:271–277PubMedCrossRef
9.
Zurück zum Zitat Leocani L, Rovaris M, Boneschi FM, Medaglini S, Rossi P, Martinelli V et al (2006) Multimodal evoked potential to assess the evolution of multiole sclerosis: a longitudinal study. J Neurol Neurosurg Psychiatry 77:1030–1035PubMedCrossRef Leocani L, Rovaris M, Boneschi FM, Medaglini S, Rossi P, Martinelli V et al (2006) Multimodal evoked potential to assess the evolution of multiole sclerosis: a longitudinal study. J Neurol Neurosurg Psychiatry 77:1030–1035PubMedCrossRef
10.
Zurück zum Zitat McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127PubMedCrossRef McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127PubMedCrossRef
11.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr res 12(3):189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr res 12(3):189–198PubMedCrossRef
12.
Zurück zum Zitat Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452PubMed Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452PubMed
13.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRef Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRef
14.
Zurück zum Zitat Hummel T, Klimek L, Welge-Lüssen AG, Gudziol H, Renner B et al (2000) Chemosensory evoked potential for clinical diagnosis of olfactory disorders. HNO 48:481–485PubMedCrossRef Hummel T, Klimek L, Welge-Lüssen AG, Gudziol H, Renner B et al (2000) Chemosensory evoked potential for clinical diagnosis of olfactory disorders. HNO 48:481–485PubMedCrossRef
15.
Zurück zum Zitat Hummel T, Kobal G (2001) Olfactory event-related potential. In: Simon SA, Nicolelis MAL (eds) Methods and frontiers in chemosensory research. CRC Press, Boca Raton, pp 429–464 Hummel T, Kobal G (2001) Olfactory event-related potential. In: Simon SA, Nicolelis MAL (eds) Methods and frontiers in chemosensory research. CRC Press, Boca Raton, pp 429–464
16.
Zurück zum Zitat Goektas O, Fleiner F, Sedlmaier B, Bauknecht C (2006) Correlation of olfactory dysfunction of different etiologies in MRI and comparison with subjective and objective olfactometry. Eur J Radiol 71:469–473CrossRef Goektas O, Fleiner F, Sedlmaier B, Bauknecht C (2006) Correlation of olfactory dysfunction of different etiologies in MRI and comparison with subjective and objective olfactometry. Eur J Radiol 71:469–473CrossRef
17.
Zurück zum Zitat Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S (1996) “Sniffin’ sticks”: screening of olfactory performance. Rhinology 34:222–226PubMed Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S (1996) “Sniffin’ sticks”: screening of olfactory performance. Rhinology 34:222–226PubMed
18.
Zurück zum Zitat Kobal G, Klimek L, Wolfensberger M, Gudziol H, Temmel A, Owen CM et al (2000) Multicenter investigation of 1036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 257:205–211PubMedCrossRef Kobal G, Klimek L, Wolfensberger M, Gudziol H, Temmel A, Owen CM et al (2000) Multicenter investigation of 1036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 257:205–211PubMedCrossRef
19.
Zurück zum Zitat Heilmann S, Strehle G, Rosenheim K, Damm M, Hummel T (2002) Clinical assessment of retronasal olfactory function. Arch Otolaryngol Head Neck Surg 128:414–418PubMed Heilmann S, Strehle G, Rosenheim K, Damm M, Hummel T (2002) Clinical assessment of retronasal olfactory function. Arch Otolaryngol Head Neck Surg 128:414–418PubMed
20.
Zurück zum Zitat Landis BN, Giger R, Ricchetti A, Leuchter I, Hugentobler M, Hummel T (2003) Retronasal olfactory function in nasal polyposis. Laryngoscope 113:1993–1997PubMedCrossRef Landis BN, Giger R, Ricchetti A, Leuchter I, Hugentobler M, Hummel T (2003) Retronasal olfactory function in nasal polyposis. Laryngoscope 113:1993–1997PubMedCrossRef
21.
Zurück zum Zitat Mueller C, Kallert S, Renner B, Stiassny K, Temmel AF, Hummel T et al (2003) Quantitative assessment of gustatory function in a clinical context using impregnated “taste strips”. Rhinology 41:2–6PubMed Mueller C, Kallert S, Renner B, Stiassny K, Temmel AF, Hummel T et al (2003) Quantitative assessment of gustatory function in a clinical context using impregnated “taste strips”. Rhinology 41:2–6PubMed
23.
Zurück zum Zitat Martzke JS, Kopala LC, Good KP (1997) Olfactory dysfunction in neuropsychiatric disorders. Review and methodological consideration. Soc Biol Psychiatry 42:721–732CrossRef Martzke JS, Kopala LC, Good KP (1997) Olfactory dysfunction in neuropsychiatric disorders. Review and methodological consideration. Soc Biol Psychiatry 42:721–732CrossRef
24.
Zurück zum Zitat Landis BN, Scheibe M, Weber C, Berger R, Brämerson A, Bende M et al (2010) Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol 257:1303–1308PubMedCrossRef Landis BN, Scheibe M, Weber C, Berger R, Brämerson A, Bende M et al (2010) Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol 257:1303–1308PubMedCrossRef
25.
Zurück zum Zitat Beatty WW, Donald E, Goodkin MD (1990) Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. Arch Neurol 47:297–301PubMedCrossRef Beatty WW, Donald E, Goodkin MD (1990) Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. Arch Neurol 47:297–301PubMedCrossRef
Metadaten
Titel
Psychophysiological and electrophysiological testing of olfactory and gustatory function in patients with multiple sclerosis
verfasst von
Sarah Bettina Dahlslett
Oender Goektas
Felix Schmidt
Lutz Harms
Heidi Olze
Franca Fleiner
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 4/2012
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-011-1812-7

Weitere Artikel der Ausgabe 4/2012

European Archives of Oto-Rhino-Laryngology 4/2012 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.